retatrutide phase 3 results october 2025 Today, we shared new data from two trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v retatrutide mechanism of action retatrutide

You just need it spread out

Exenatide (Byetta, AstraZeneca) is a synthetic version of exendin-4, a GLP-1R agonist found in the saliva of the Gila monster ( Heloderma suspectum )

doi: 10.1016/j.neuropharm.2015.10.023 156 SaraivaC.Barata-AntunesS.SantosT.FerreiroE.CristovaoA

At Leva Medical , our specialists closely track these clinical developments to ensure patients in Queens, Elmhurst, and Forest Hills have access to the safest and most effective options available

Rather than dismissing or criticizing patients for their choices, clinicians should objectively evaluate potential risks, verify exactly what the patient is taking, and develop a safe, evidence-based treatment plan that preserves trust while strengthening the therapeutic relationship